Comparison

Anti-Methacryllysine Mouse mAb

Item no. PTM-1501
Manufacturer PTM Biolabs
Amount 100 ul
Category
Type Antibody Monoclonal
Format Lyophilized powder
Applications WB, IHC-P
Clone 3-1-4
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host Mouse
Isotype IgG
Conjugate/Tag Unconjugated
Citations Delaney Kyle, et al. Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2. Cell Discovery, 2021. https://www.nature.com/articles/s41421-021-00344-4.
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Alias Kmea
Shipping Condition Room temperature
Available
Manufacturer - Type
Primary Antibodies
Manufacturer - Category
Pan PTM Antibodies
Shipping Temperature
Ambient temperature
Storage Conditions
Store at -20°C. Avoid freeze/thaw cycles.
Molecular Weight
Multiple
Stability
Stable for 12 months from date of receipt/reconstitution.
Manufacturer - Research Area
Post-Translational Modificaiton
Manufacturer - Reactivity
All
Product description
Histones are subject to a variety of enzyme catalyzed modifications, including acetylation, methylation, phosphorylation, ubiquitylation, etc. Histone lysine methylacrylylation (Kmea) is a novel post-translational modification. It is a structural isomer of crotonyllysine, with a different mechanism and function. Specifically, methacrylate is the metabolic precursor of Kmea, and HAT1, SIRT1 and SIRT2 are the writer and erasers of Kmea, respectively. In addition, 27 histone Kmea sites were identified in HeLa cells. Leigh syndrome (LS) is a neurological disease characterized by mitochondrial defects. Accumulation of methacrylyl-coA is identified in LS patients with genetic mutations in short-chain enoyl-CoA hydratase (ECHS1) and 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) in the metabolic pathway of valine.The discovery of Kmea suggests a new direction for the pathological role of methylacrylyl-coA accumulation.
Purification Method
Protein A purified
Manufacturer - Specificity
Anti-Methacryllysine Mouse mAb detects proteins post-translationally modified by methacrylation on lysine residues. This pan antibody recognizes methacrylated lysine independent of its surrounding sequences.
Formula
PBS, Glycerol, BSA
PTM
Methacryl
Modification Site
Lys
Immunogen
Methacrylated lysine peptides
Clonality
Recombinant Monoclonal
Background
Histones are subject to a variety of enzyme catalyzed modifications, including acetylation, methylation, phosphorylation, ubiquitylation, etc. Histone lysine methylacrylylation (Kmea) is a novel post-translational modification. It is a structural isomer of crotonyllysine, with a different mechanism and function. Specifically, methacrylate is the metabolic precursor of Kmea, and HAT1, SIRT1 and SIRT2 are the writer and erasers of Kmea, respectively. In addition, 27 histone Kmea sites were identified in HeLa cells. Leigh syndrome (LS) is a neurological disease characterized by mitochondrial defects. Accumulation of methacrylyl-coA is identified in LS patients with genetic mutations in short-chain enoyl-CoA hydratase (ECHS1) and 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) in the metabolic pathway of valine.The discovery of Kmea suggests a new direction for the pathological role of methylacrylyl-coA accumulation.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ul
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close